Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TGF-β mediated drug resistance in solid cancer.
Turati M, Mousset A, Issa N, Turtoi A, Ronca R. Turati M, et al. Among authors: ronca r. Cytokine Growth Factor Rev. 2023 Jun-Aug;71-72:54-65. doi: 10.1016/j.cytogfr.2023.04.001. Epub 2023 Apr 11. Cytokine Growth Factor Rev. 2023. PMID: 37100675 Review.
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells.
Masci D, Puxeddu M, Di Magno L, D'Ambrosio M, Parisi A, Nalli M, Bai R, Coluccia A, Sciò P, Orlando V, D'Angelo S, Biagioni S, Urbani A, Hamel E, Nocentini A, Filiberti S, Turati M, Ronca R, Kopecka J, Riganti C, Fionda C, Bordone R, Della Rocca G, Canettieri G, Supuran CT, Silvestri R, La Regina G. Masci D, et al. Among authors: ronca r. J Med Chem. 2023 Nov 9;66(21):14824-14842. doi: 10.1021/acs.jmedchem.3c01424. Epub 2023 Oct 30. J Med Chem. 2023. PMID: 37902628 Free PMC article.
Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells.
Biagiotti G, Cazzoli R, Andreozzi P, Aresta G, Francesco M, Mangini C, di Gianvincenzo P, Tobia C, Recchia S, Polito L, Severi M, Vittorio O, Cicchi S, Moya SE, Ronca R, Albini A, Berti D, Orecchia R, Garibaldi C, Minucci S, Richichi B. Biagiotti G, et al. Among authors: ronca r. Nanoscale Horiz. 2024 May 22. doi: 10.1039/d4nh00042k. Online ahead of print. Nanoscale Horiz. 2024. PMID: 38775782
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness.
Monti M, Benerini Gatta L, Bugatti M, Pezzali I, Picinoli S, Manfredi M, Lavazza A, Vanella VV, De Giorgis V, Zanatta L, Missale F, Lonardi S, Zanetti B, Bozzoni G, Cadei M, Abate A, Vergani B, Balzarini P, Battocchio S, Facco C, Turri-Zanoni M, Castelnuovo P, Nicolai P, Fonsatti E, Leone BE, Marengo E, Sigala S, Ronca R, Perego M, Lombardi D, Vermi W. Monti M, et al. Among authors: ronca r. J Transl Med. 2024 Jan 8;22(1):35. doi: 10.1186/s12967-023-04784-2. J Transl Med. 2024. PMID: 38191367 Free PMC article.
Proteasome inhibitors as anticancer agents.
Gazzaroli G, Angeli A, Giacomini A, Ronca R. Gazzaroli G, et al. Among authors: ronca r. Expert Opin Ther Pat. 2023 Nov;33(11):775-796. doi: 10.1080/13543776.2023.2272648. Epub 2024 Jan 11. Expert Opin Ther Pat. 2023. PMID: 37847492 Review.
133 results